VMC
53
-3
AVGO
45
3
AAL
48
3
INTU
56
-7
COP
47
3
KMB
36
2
CNX
42
4
KMX
40
2
MRK
66
-2
BLK
58
-3
SEE
52
2
PWR
54
-2
MO
50
2
ROK
44
-2
HRL
32
-3
NAVI
32
2
GWW
58
-6
AES
61
4
OXY
45
4
ACN
54
-2
VMC
53
-3
AVGO
45
3
AAL
48
3
INTU
56
-7
COP
47
3
KMB
36
2
CNX
42
4
KMX
40
2
MRK
66
-2
BLK
58
-3
SEE
52
2
PWR
54
-2
MO
50
2
ROK
44
-2
HRL
32
-3
NAVI
32
2
GWW
58
-6
AES
61
4
OXY
45
4
ACN
54
-2
Financhill
Back

PIMCO Corporate & Income Opportunity Fund Vs. Rapt Therapeutics, Inc. Industry Stock Comparison

Sell
48

PTY
PIMCO Corporate & Income Opportunity Fund

Last Price:
$12.90
Seasonality Move:
-0.06%
Sell
38

RAPT
Rapt Therapeutics, Inc.

Last Price:
$33.91
Seasonality Move:
-28.15%
Sell
48
PIMCO Corporate & Income Opportunity Fund (PTY) is a Sell

Is PIMCO Corporate & Income Opportunity Fund a Buy, Sell or Hold?

  • The current PIMCO Corporate & Income Opportunity Fund [PTY] share price is $12.96. The Score for PTY is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • PTY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Rapt Therapeutics, Inc. (RAPT) is a Sell

Is Rapt Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Rapt Therapeutics, Inc. [RAPT] share price is $33.38. The Score for RAPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RAPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTY Stock Price Chart

What is PIMCO Corporate & Income Opportunity Fund's stock price today?

  • The PIMCO Corporate & Income Opportunity Fund share price today is $12.96
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTY is experiencing buying pressure, which is a positive indicator for future bullish movement.

RAPT Stock Price Chart

What is Rapt Therapeutics, Inc.'s stock price today?

  • The Rapt Therapeutics, Inc. share price today is $33.38
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAPT is experiencing selling pressure, which indicates risk of future bearish movement.

PTY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.58 Buy
Relative Strength Index (14 RSI): 42.49 Sell
Chaikin Money Flow: 1827842 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.89 - 13.21) Sell
Bollinger Bands (100): (13.23 - 14.33) Sell

RAPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.71 Buy
Relative Strength Index (14 RSI): 49.51 Sell
Chaikin Money Flow: -220916 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.11 - 35.93) Sell
Bollinger Bands (100): (16.49 - 33.77) Buy

PTY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.89 Buy
20-day SMA: 13.01 Sell
50-day SMA: 13.31 Sell
200-day SMA: 13.78 Sell
8-day EMA: 11.17 Buy
20-day EMA: 7.1 Buy
50-day EMA: 3.53 Buy
200-day EMA: 0.99 Buy

RAPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.03 Sell
20-day SMA: 34.65 Sell
50-day SMA: 31.71 Buy
200-day SMA: 16.89 Buy
8-day EMA: 31.26 Buy
20-day EMA: 20.72 Buy
50-day EMA: 10.54 Buy
200-day EMA: 3 Buy

PIMCO Corporate & Income Opportunity Fund Earnings Growth & PTY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rapt Therapeutics, Inc. Earnings Growth & RAPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and a decrease next year of $1.22 per share.

PIMCO Corporate & Income Opportunity Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rapt Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):